Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Beyondspring Inc (BYSI)

Beyondspring Inc (BYSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beyondspring Inc 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005 USA

www.beyondspringpharma.com P: 646-305-6387 F: 646-882-4228

Description:

BeyondSpring Inc. is a clinical stage biopharmaceutical company. It focused on the development of cancer therapies. The Company's lead product consists of into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia. BeyondSpring Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 87,815
Enterprise Value, $K 64,485
Shares Outstanding, K 39,029
Annual Sales, $ 1,350 K
Annual Net Income, $ -33,280 K
Last Quarter Sales, $ 340 K
Last Quarter Net Income, $ -9,510 K
EBIT, $ -66,240 K
EBITDA, $ -66,010 K
60-Month Beta 0.32
% of Insider Shareholders 29.31%
% of Institutional Shareholders 40.29%
Float, K 27,590
% Float 70.69%
Short Volume Ratio 0.54

Growth:

1-Year Return 151.96%
3-Year Return -77.45%
5-Year Return -85.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 80.68%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 04/16/24
Earnings Per Share ttm -1.64
EPS Growth vs. Prev Year -19.61%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BYSI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -2,465.19%
Debt/Equity 0.00
Price/Sales 48.15
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.67
Interest Coverage -1,805.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar